Biblio

48 resultats trouvés
Filtres: Auteur is Tiberghien, Pierre  [Clear All Filters]
P
Gallian P, Barlet V, Mouna L, Gross S, Morel P, Le Cam S, Ricard C, Maugard C, Pouchol E, Flan B et al..  2019.  Persisting higher prevalence of hepatitis A virus RNA in blood donors, France, 2018. EUROSURVEILLANCE. 24:1900695.
Ducloux D, Courivaud C, Bamoulid J, Crepin T, Chalopin J-M, Tiberghien P, Saas P.  2014.  Polyclonal Antithymocyte Globulin and Cardiovascular Disease in Kidney Transplant Recipients. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 25:1349-1356.
Lauwers E, Lalli G, Brandner S, Collinge J, Compernolle V, Duyckaerts C, Edgren G, Haik S, Hardy J, Helmy A et al..  2020.  Potential human transmission of amyloid beta pathology: surveillance and risks. LANCET NEUROLOGY. 19:872-878.
Lauwers E, Lalli G, Brandner S, Collinge J, Compernolle V, Duyckaerts C, Edgren G, Haik S, Hardy J, Helmy A et al..  2020.  Potential human transmission of amyloid beta pathology: surveillance and risks. LANCET NEUROLOGY. 19:872-878.
Morand C, Coudurier N, Rolland C, Thoret S, Legrand D, Tiberghien P, Bosson J-L.  2016.  Prevention of syncopal-type reactions after whole blood donation: a cluster-randomized trial assessing hydration and muscle tension exercise. TRANSFUSION. 56:2412-2421.
Gamonet C, Desmarets M, Mourey G, Biichle S, Aupet S, Laheurte C, Francois A, Resch E, Bigey F, Binda D et al..  2020.  Processing methods and storage duration impact extracellular vesicle counts in red blood cell units. BLOOD ADVANCES. 4:5527-5539.
Sut C, Hamzeh-Cognasse H, Laradi S, Bost V, Aubrege C, Acquart S, Vignal M, Boutahar N, Arthaud CAntoine, Eyraud MAnge et al..  2017.  Properties of donated red blood cell components from patients with hereditary hemochromatosis. TRANSFUSION. 57:166-177.
Gallian P, de Lamballerie X, Salez N, Piorkowski G, Richard P, Paturel L, Djoudi R, Leparc-Goffart I, Tiberghien P, Chiaroni J et al..  2014.  Prospective detection of chikungunya virus in blood donors, Caribbean 2014 (vol 123, pg 3679, 2014). BLOOD. 124:1695-1696.
T
Garban F, Vilotitch A, Tiberghien P, Bosson JLuc, Grp EFFIPAPStudy.  Submitted.  The impact of pathogen-reduced platelets in acute leukaemia treatment on the total blood product requirement: a subgroup analysis of an EFFIPAP randomised trial. TRANSFUSION MEDICINE.
Xhaard A, Miekoutima E, Pirenne F, Francois A, Tiberghien P, Sebert M, Ades L, Fenaux P, Lepretre A-C.  Submitted.  The transfusion of non-prophylactically RH-KEL1 antigen-matched red blood cells is feasible in selected myelodysplastic syndrome and acute myeloid leukaemia patients. VOX SANGUINIS.
Vallion R, Bonnefoy F, Daoui A, Vieille L, Tiberghien P, Saas P, Perruche S.  2015.  Transforming growth factor- released by apoptotic white blood cells during red blood cell storage promotes transfusion-induced alloimmunomodulation. TRANSFUSION. 55:1721-1735.
Cappy P, Barlet V, Lucas Q, Tinard X, Pillonel J, Gross S, Tiberghien P, Laperche S.  2019.  Transfusion of HIV-infected blood products despite highly sensitive nucleic acid testing. TRANSFUSION. 59:2046-2053.
Zuber J, Boyer O, Neven B, Berthaud R, Rabah MOuld, Jollet I, Renac V, Ansart-Pirenne H, Noizat-Pirenne F, Gross S et al..  2019.  Transfusion of Plasma Containing Organ Donor-Specific Anti-HLA Antibodies to Treat Refractory Acute GVHD After Kidney Transplantation in a Setting of Primary Immunodeficiency. TRANSFUSION. 59:96A.
Zuber J, Boyer O, Neven B, Berthaud R, Rabah MOuld, Jollet I, Renac V, Ansart-Pirenne H, Noizat-Pirenne F, Gross S et al..  2019.  Transfusion of Plasma Containing Organ Donor-Specific Anti-HLA Antibodies to Treat Refractory Acute GVHD After Kidney Transplantation in a Setting of Primary Immunodeficiency. TRANSFUSION. 59:96A.
Gallian P, Pouchol E, Djoudi R, Lhomme S, Mouna L, Gross S, Bierling P, Assal A, Kamar N, Mallet V et al..  2019.  Transfusion-Transmitted Hepatitis E Virus Infection in France. TRANSFUSION MEDICINE REVIEWS. 33:146-153.

Pages